Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
human papillomavirus quadrivalent (types 6, 11, 16 and 18) vaccine, recombinant (Gardasil) (1 trial)
recombinant human papillomavirus virus type 6/11 bivalent vaccine (1 trial)
Uterine Cervical Neoplasms (Phase 3)
Trials (1 total)
Trial APIs (2 total)